Baby Formula Makers Abbott and Reckitt See Stocks Slide

Abbott, Reckitt face new trial over premature infant formula
A Missouri judge has ordered Abbott Laboratories and Reckitt Benckiser unit Mead Johnson to face a new trial over allegations that they failed to warn a mother about the risks of their specialized baby formulas for premature infants,
Baby Formula Makers Abbott and Reckitt See Stocks Slide as Judge Allows Retrial
Infant formula makers Abbott and Reckitt saw their stocks decline Friday after a judge ruled plaintiffs could pursue a new trial against the companies.
Abbott and Reckitt Fall on News of New Infant Formula Trial
Abbott Laboratories and Reckitt Benckiser Group Plc shares fell as a judge ordered a new trial after rejecting a verdict that had cleared the companies of liability over claims they hid potential risks of their premature-infant formulas.
Abbott Labs, Reckitt Benckiser Shares Fall After New Ruling on Infant Formula Case
Shares of Abbott Laboratories and Reckitt Benckiser fell Friday after a judge ruled a new trial could be heard involving a case on their infant formula products that had already seen a ruling in their favor.
Reckitt Shares Drop on Infant Formula Retrial in U.S.
Reckitt--which houses Dettol, Harpic and Durex among its brands--said the judge ordered a retrial of a Missouri lawsuit that had found in October that subsidiary Mead Johnson wasn't liable for injuries suffered by a child who consumed its formula designed for premature babies.
That baby formula trial Abbott and Reckitt won isn't over just yet
Back in October, a jury found North Chicago-based Abbott and Reckitt’s formula subsidiary Mead Johnson not responsible for a baby developing necrotizing enterocolitis, or NEC, from their cow-milk-based formulas. NEC is a serious, and sometimes deadly, gastrointestinal disease that primarily afflicts premature infants.
Reckitt still assessing options for Mead Johnson infant-formula “exit”
CEO Kris Licht said last week that Reckitt has received “interest” from prospective buyers for its nutrition unit housing Mead Johnson.
Reckitt says US court grants new trial in premature-infant formula case
Reckitt said on Friday a U.S. circuit court has ruled that a new trial could be sought by plaintiffs in a case that had accused the London-listed firm and Abbott of failing to warn of the risks of premature baby formulas.
Reuters11d
Strepsils maker Reckitt misses sales forecast on late flu season, but lower costs help
LONDON, March 6 (Reuters) - Britain's Reckitt Benckiser (RKT.L), opens new tab, the maker of Strepsils throat lozenges and ...
Reckitt slumps on renewed litigation uncertainty - RBC Capital Markets
In March 2024, a U.S. court in Illinois awarded $60 million in damages to a mother of a baby that died from necrotizing ...
Keir Starmer plans to reshape Britain’s ‘flabby’ state. But don’t compare him to Elon Musk
Britain's Prime Minister Keir Starmer has won praise for his efforts to marshal international support for Ukraine as ...
UK's Starmer calls on allies to make concrete commitments at Ukraine meeting
British Prime Minister Keir Starmer will urge around 25 world leaders on Saturday to make concrete commitments to support ...
Reckitt Benckiser price target raised to 5,920 GBp from 5,177 GBp at Berenberg
Berenberg analyst Fulvio Cazzol raised the firm’s price target on Reckitt Benckiser (RBGLY) to 5,920 GBp from 5,177 GBp and keeps a Hold rating ...